Clinical Trial: Developing Hyperpolarized Gas MRI Signatures to Detect and Manage Acute Cellular Rejection

U.S., July 3 -- ClinicalTrials.gov registry received information related to the study (NCT07046910) titled 'Developing Hyperpolarized Gas MRI Signatures to Detect and Manage Acute Cellular Rejection' on June 14.

Brief Summary: Lung transplantation (LT) is the only definitive therapy for many patients with end-stage lung diseases. The supply of donors' lungs is the biggest bottleneck to performing a lung transplant, and many patients die while waiting. Acute Cellular Rejection (ACR) is a significant risk factor for developing chronic allograft failure, a primary reason for death in this patient population. These observations highlight the importance of early diagnosis and management of ACR to prevent chronic graft failure. The preliminary r...